A. AYDINER And M. Sari, "Epidermal growth factor receptor (EGFR) exon 20 mutations in EGFR-tyrosine kinase inhibitors (EGFR-TKIs) naive non-small cell lung carcinoma (NSCLC) and response to erlotinib therapy," JOURNAL OF CLINICAL ONCOLOGY , vol.36, no.15, 2018
AYDINER, A. And Sari, M. 2018. Epidermal growth factor receptor (EGFR) exon 20 mutations in EGFR-tyrosine kinase inhibitors (EGFR-TKIs) naive non-small cell lung carcinoma (NSCLC) and response to erlotinib therapy. JOURNAL OF CLINICAL ONCOLOGY , vol.36, no.15 .
AYDINER, A., & Sari, M., (2018). Epidermal growth factor receptor (EGFR) exon 20 mutations in EGFR-tyrosine kinase inhibitors (EGFR-TKIs) naive non-small cell lung carcinoma (NSCLC) and response to erlotinib therapy. JOURNAL OF CLINICAL ONCOLOGY , vol.36, no.15.
AYDINER, Adnan, And Murat SARI. "Epidermal growth factor receptor (EGFR) exon 20 mutations in EGFR-tyrosine kinase inhibitors (EGFR-TKIs) naive non-small cell lung carcinoma (NSCLC) and response to erlotinib therapy," JOURNAL OF CLINICAL ONCOLOGY , vol.36, no.15, 2018
AYDINER, Adnan And Sari, Murat. "Epidermal growth factor receptor (EGFR) exon 20 mutations in EGFR-tyrosine kinase inhibitors (EGFR-TKIs) naive non-small cell lung carcinoma (NSCLC) and response to erlotinib therapy." JOURNAL OF CLINICAL ONCOLOGY , vol.36, no.15, 2018
AYDINER, A. And Sari, M. (2018) . "Epidermal growth factor receptor (EGFR) exon 20 mutations in EGFR-tyrosine kinase inhibitors (EGFR-TKIs) naive non-small cell lung carcinoma (NSCLC) and response to erlotinib therapy." JOURNAL OF CLINICAL ONCOLOGY , vol.36, no.15.
@article{article, author={Adnan AYDINER And author={Murat SARI}, title={Epidermal growth factor receptor (EGFR) exon 20 mutations in EGFR-tyrosine kinase inhibitors (EGFR-TKIs) naive non-small cell lung carcinoma (NSCLC) and response to erlotinib therapy}, journal={JOURNAL OF CLINICAL ONCOLOGY}, year=2018}